Perrigo ROE 2006-2018 | PRGO

Current and historical return on equity (ROE) values for Perrigo (PRGO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Perrigo ROE for the three months ending September 30, 2018 was 11.32%.
Perrigo ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.12B $5.66B 2.04%
2018-06-30 $0.24B $5.90B 3.87%
2018-03-31 $0.13B $6.21B 2.11%
2017-12-31 $0.12B $6.17B 1.97%
2017-09-30 $-1.31B $6.04B -21.73%
2017-06-30 $-2.95B $6.08B -46.07%
2017-03-31 $-3.41B $6.07B -47.78%
2016-12-31 $-4.01B $5.96B -49.82%
2016-09-30 $-2.83B $7.48B -31.10%
2016-06-30 $-0.98B $9.05B -9.86%
2016-03-31 $-0.46B $9.73B -4.50%
2015-12-31 $0.04B $10.11B 0.42%
2015-09-30 $0.29B $10.73B 2.82%
2015-06-30 $0.12B $10.66B 1.26%
2015-03-31 $0.14B $9.59B 1.57%
2014-12-31 $0.21B $9.72B 2.40%
2014-09-30 $0.06B $8.72B 0.67%
2014-06-30 $0.07B $8.69B 1.03%
2014-03-31 $0.07B $8.56B 1.34%
2013-12-31 $0.14B $8.50B 3.53%
2013-09-30 $0.33B $2.47B 14.40%
2013-06-30 $0.32B $2.33B 15.02%
2013-03-31 $0.32B $2.23B 15.90%
2012-12-31 $0.33B $2.11B 17.04%
2012-09-30 $0.32B $1.97B 17.83%
2012-06-30 $0.29B $1.85B 16.82%
2012-03-31 $0.29B $1.77B 17.66%
2011-12-31 $0.26B $1.63B 16.90%
2011-09-30 $0.25B $1.54B 17.15%
2011-06-30 $0.25B $1.53B 18.50%
2011-03-31 $0.25B $1.43B 20.11%
2010-12-31 $0.23B $1.31B 19.38%
2010-09-30 $0.20B $1.21B 18.14%
2010-06-30 $0.18B $1.09B 17.06%
2010-03-31 $0.18B $1.06B 17.81%
2009-12-31 $0.16B $0.99B 17.12%
2009-09-30 $0.12B $0.96B 13.85%
2009-06-30 $0.11B $0.92B 12.54%
2009-03-31 $0.11B $0.84B 12.50%
2008-12-31 $0.10B $0.83B 11.74%
2008-09-30 $0.11B $0.89B 12.80%
2008-06-30 $0.11B $0.93B 12.77%
2008-03-31 $0.11B $0.86B 13.49%
2007-12-31 $0.09B $0.82B 11.16%
2007-09-30 $0.07B $0.77B 9.86%
2007-06-30 $0.06B $0.75B 7.82%
2007-03-31 $0.06B $0.71B 8.15%
2006-12-31 $0.06B $0.69B 9.01%
2006-09-30 $0.06B $0.66B 9.95%
2006-06-30 $0.06B $0.64B 9.58%
2006-03-31 $0.06B $0.62B 9.78%
2005-12-31 $-0.34B $0.61B -56.86%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $8.596B $4.946B
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00